Professor Paul Knoepfler predicts easier peptide compounding in 2026 driven by RFK Jr., amid risks and limited data on many unproven peptides. Educational summary of public regulatory analysis.
Put your login / registration information here. You can edit this in the admin site.
All peptide products offered by Sumrday, LLC are sold for research, laboratory, or analytical purposes only and are not intended for human or animal consumption.
Statements on this website have not been evaluated by the U.S. Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
Sumrday, LLC is a product supplier and is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.